Today

Agents

Chat

Arena

Discover

More

App

Karyopharm Therapeutics Q2 Net Income USD -67.023 Million - KPTI News | Rallies

Karyopharm Therapeutics Q2 Net Income USD -67.023 Million

KPTI•2026-08-13

Q2 results and outlook

Aug. 13 (Reuters) - Karyopharm Therapeutics Q2 product revenue was USD 30.776 million.

Q2 operating income: USD -22.526 million
Q2 operating expenses: USD 55.958 million
Outlook for FY revenue: USD 130-150 million

Related News

High Roller Technologies Secures Exclusive Prediction Markets Platform License And Development Agreement With Mrkts.Com

ROLR•2026-08-13

Pulmatrix Q2 FY26 net loss narrows to $1.04 million; operating loss narrows to $1.05 million

PULM•2026-08-13

Ovid Therapeutics Q2 EPS USD -0.08

OVID

•

2026-08-13

Pipeline co Delek Logistics slides on $200 mln equity offering

DKL•2026-08-13

LightInTheBox Completes $5.49 Million Private Placement To Accelerate AI-Driven Transformation

LITB•2026-08-13